PeptiDream Inc. (PPTDF)
7.00
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
PeptiDream Enterprise Value : 851.28M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 851.28M |
| September 04, 2026 | 851.28M |
| September 03, 2026 | 851.28M |
| September 02, 2026 | 851.28M |
| September 01, 2026 | 851.28M |
| August 31, 2026 | 848.07M |
| August 28, 2026 | 848.07M |
| August 27, 2026 | 876.99M |
| August 26, 2026 | 813.03M |
| August 25, 2026 | 813.03M |
| August 24, 2026 | 813.03M |
| August 21, 2026 | 813.03M |
| August 20, 2026 | 813.03M |
| August 19, 2026 | 813.03M |
| August 18, 2026 | 722.71M |
| August 17, 2026 | 722.71M |
| August 14, 2026 | 722.71M |
| August 13, 2026 | 722.71M |
| August 12, 2026 | 722.71M |
| August 11, 2026 | 722.71M |
| August 10, 2026 | 722.71M |
| August 07, 2026 | 722.71M |
| August 06, 2026 | 722.71M |
| August 05, 2026 | 722.71M |
| August 04, 2026 | 707.28M |
| Date | Value |
|---|---|
| August 03, 2026 | 721.68M |
| July 31, 2026 | 721.68M |
| July 30, 2026 | 721.68M |
| July 29, 2026 | 721.68M |
| July 28, 2026 | 721.68M |
| July 27, 2026 | 721.68M |
| July 24, 2026 | 721.68M |
| July 23, 2026 | 721.68M |
| July 22, 2026 | 721.68M |
| July 21, 2026 | 721.68M |
| July 20, 2026 | 721.68M |
| July 17, 2026 | 721.68M |
| July 16, 2026 | 721.68M |
| July 15, 2026 | 806.28M |
| July 14, 2026 | 806.28M |
| July 13, 2026 | 806.28M |
| July 10, 2026 | 806.28M |
| July 09, 2026 | 806.28M |
| July 08, 2026 | 806.28M |
| July 07, 2026 | 806.28M |
| July 06, 2026 | 806.28M |
| July 02, 2026 | 722.71M |
| July 01, 2026 | 722.71M |
| June 30, 2026 | 722.71M |
| June 29, 2026 | 713.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pharma Foods International Co., Ltd. | 206.45M |
| NovelStem International Corp. | 2.190M |
| Brainstorm Cell Therapeutics, Inc. | 12.28M |
| Enlivex Ltd. | 12.34M |
| Summit Therapeutics, Inc. | 13.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.182M |
| Revenue (Quarterly) | 28.00M |
| Total Expenses (Quarterly) | 35.18M |
| EPS Diluted (Quarterly) | -0.0559 |
| Gross Profit Margin (Quarterly) | 43.48% |
| Profit Margin (Quarterly) | -25.65% |
| Earnings Yield | -2.60% |
| Normalized Earnings Yield | -2.603 |